Newron Pharmaceuticals SpA - ESG Rating & Company Profile powered by AI
This Disclosure rating includes 17 UN SDGs including: 'Zero Hunger', 'Reduced Inequalities' and 'Peace, Justice & Strong Institutions'. Full Sustainability assessment of Newron Pharmaceuticals SpA are reached by signing in. The assessment of Newron Pharmaceuticals SpA uses information from across the web and also from available documents by Newron Pharmaceuticals SpA.
Newron Pharmaceuticals SpA in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.8; made up of an environmental score of 4.0, social score of 5.3 and governance score of 8.0.
5.8
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 521 | Smruthi Organics Ltd | 5.9 | High |
| 521 | Vectura Group PLC | 5.9 | High |
| 541 | Newron Pharmaceuticals SpA | 5.8 | High |
| 541 | Cantargia AB | 5.8 | High |
| 541 | Amplia Therapeutics Ltd | 5.8 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Newron Pharmaceuticals SpA have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA disclose current and historical energy intensity?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA report the average age of the workforce?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA disclose its ethnicity pay gap?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA disclose cybersecurity risks?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA offer flexible work?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA conduct supply chain audits?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Newron Pharmaceuticals SpA conduct 360 degree staff reviews?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA disclose the individual responsible for D&I?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA disclose water use targets?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA have careers partnerships with academic institutions?
Sign up for free to unlockDid Newron Pharmaceuticals SpA have a product recall in the last two years?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA disclose incidents of discrimination?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Newron Pharmaceuticals SpA issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA disclose parental leave metrics?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA disclose the pay ratio of women to men?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Newron Pharmaceuticals SpA involved in embryonic stem cell research?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA disclose its waste policy?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA report according to TCFD requirements?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA disclose energy use targets?
Sign up for free to unlockDoes Newron Pharmaceuticals SpA disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Newron Pharmaceuticals SpA have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Newron Pharmaceuticals SpA
These potential risks are based on the size, segment and geographies of the company.
Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for the treatment of levodopa induced dyskinesia. It also develops Evenamide for Schizophrenia and treatment resistant schizophrenia; and Ralfinamide for orphan indication in neuropathic pain. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.